Tarsus Pharmaceuticals, Inc. (TARS) Investor Relations Documents

Tarsus Pharmaceuticals, Inc. (TARS) investor relations documents from the company's IR site: 8 presentations, 30 press releases; latest deck 2026-08-18. Read in-app with summaries. First-party data.

Tarsus Corporate Presentation — Tarsus Pharmaceuticals' August 2026 investor document highlights XDEMVY's strong growth in Demodex blepharitis, projecting over $2B in peak US sales, and outlines a robust pipeline with multiple potential FDA approvals by 2031.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-18PresentationTarsus Corporate Presentation
2026-08-06Press releaseTarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
2026-08-06Press releaseTarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position
2026-08-06Earnings deckTarsus Second Quarter 2026 Earnings Presentation
2026-07-13Press releaseTarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth
2026-07-08Press releaseTarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101
2026-05-28Press releaseTarsus to Participate in Upcoming Investor Conferences
2026-05-14Press releaseTarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately
2026-05-07Press releaseTarsus to Participate in Upcoming Investor Conferences
2026-05-06Press releaseTarsus Reports First Quarter 2026 Financial Results and Recent Business Achievements
2026-03-31Press releaseTarsus Doses First Participant in Calliope, A Phase 2 Clinical Trial of TP-05 (lotilaner), a Novel Investigational Oral
2026-03-23Press releaseTP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a
2026-02-26Press releaseTarsus to Participate in Upcoming Investor Conferences
2025-02-25Earnings deckTarsus Fourth Quarter 2024 Earnings Presentation
2025-02-25Press releaseEarnings Release
2025-01-12PresentationTarsus Future Potential Growth Drivers Webcast Presentation
2024-11-13Earnings deckTarsus Third Quarter 2024 Earnings Presentation
2024-11-13Press releaseEarnings Release
2024-08-08Earnings deckTarsus Second Quarter 2024 Earnings Presentation
2024-08-08Press releaseEarnings Release
2024-05-08Press releaseEarnings Release
2024-02-27Press releaseEarnings Release
2023-11-09PresentationView Presentation
2023-11-09Press releaseEarnings Release
2023-08-10Press releaseEarnings Release
2023-07-25PresentationXDEMVY Approval Webcast Presentation
2023-05-09Press releaseEarnings Release
2023-03-13Press releaseEarnings Release
2022-11-09Press releaseEarnings Release
2022-08-11Press releaseEarnings Release
2022-05-10Press releaseEarnings Release
2022-03-14Press releaseEarnings Release
2021-11-09Press releaseEarnings Release
2021-08-04Press releaseEarnings Release
2021-05-11Press releaseEarnings Release
2021-03-31Press releaseEarnings Release
Press releaseTarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth
Press releaseTarsus to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

TARS overview · TARS earnings · TARS financials · TARS KPIs · TARS ownership · TARS peers · TARS filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.